Cannabis helps hundreds of patients find relief from inflammation and pain. Although there have been plenty of studies about marijuana’s potential, there is always a great need for more detailed research and additional trials. However, a group of scientists from the UK will finally conduct an extensive study on the impact of medical marijuana on patients with arthritis.
The new study is a project partnership between the pharmaceutical startup GreenLight Medicines and Ulster University. The research is worth £250,000 ($312,095), and the clinical trials may cost about €10 million ($11 million).
The research group will examine the influence of cannabis-based treatment on the symptoms of arthritis. Unlike cannabinoid studies in other spheres, the researchers at Ulster University will use real herb’s extracts. Scientists will explore which compounds of the cannabis plant are the most effective at reducing inflammation processes and identify the most suitable dosage before performing clinical tests on arthritis patients. One of the main purposes of the study is to find out which cannabinoids can be incorporated into drugs.
Big pharmaceutical companies and medical research firms are now highly interested in cannabis studies. This fact has been proved by GreenLight Medicines, a startup from Northern Ireland that recently received €500,000 ($554,935) for developing drugs using marijuana extracts. The results of the new studies will be vast: chronic inflammation is one of the main symptoms of a wide range of serious diseases, such as all forms of arthritis, including osteoarthritis and rheumatoid, inflammatory bowel disease, autoimmune disease, and even depression. Clinical trials of the drugs will take five years. While this research focuses on arthritis, there is no doubt that its findings will open doors to other areas of studies.